These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

987 related articles for article (PubMed ID: 9457424)

  • 41. [Invasive pneumococcal disease in the Czech Republic in 2000-2006].
    Motlová J; Benes C; Kríová P
    Epidemiol Mikrobiol Imunol; 2008 Feb; 57(1):14-21. PubMed ID: 18318394
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2004, through 31 December, 2005.
    Can Commun Dis Rep; 2007 Jun; 33(10):1-15. PubMed ID: 17691125
    [No Abstract]   [Full Text] [Related]  

  • 43. Genetic analysis of meningococci carried by children and young adults.
    Claus H; Maiden MC; Wilson DJ; McCarthy ND; Jolley KA; Urwin R; Hessler F; Frosch M; Vogel U
    J Infect Dis; 2005 Apr; 191(8):1263-71. PubMed ID: 15776372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic analysis of Canadian isolates of C:2a:P1.2,5 and B:2a:P1.2,5 Neisseria meningitidis strains belonging to the hypervirulent clone of ET-15.
    Tyler S; Tsang R
    Can J Microbiol; 2004 Jun; 50(6):433-43. PubMed ID: 15284889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis.
    Whalen CM; Hockin JC; Ryan A; Ashton F
    JAMA; 1995 Feb; 273(5):390-4. PubMed ID: 7823384
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Annual report of the Australian Meningococcal Surveillance Programme, 2002.
    Australian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2003; 27(2):196-208. PubMed ID: 12926735
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Meningococcal disease in England and Wales: 1995.
    Kaczmarski EB
    Commun Dis Rep CDR Rev; 1997 Apr; 7(4):R55-9. PubMed ID: 9127511
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Genetic and antigenic characteristics of Neisseria meningitidis strains isolated in the Czech Republic in 1997-1998.
    Kriz P; Musilek M; Skoczynska A; Hryniewicz W
    Eur J Clin Microbiol Infect Dis; 2000 Jun; 19(6):452-9. PubMed ID: 10947221
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Annual report of the Australian Meningococcal Surveillance Programme, 2000.
    Commun Dis Intell Q Rep; 2001 Aug; 25(3):113-21. PubMed ID: 11596711
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Susceptibility to antimicrobial drugs used in the prophylaxis of meningococcal disease: situation after an epidemic wave].
    Arreaza L; de la Fuente L; Fernández S; Vázquez JA
    Rev Esp Quimioter; 2000 Jun; 13(2):182-6. PubMed ID: 10918092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impact on disease incidence of a routine universal and catch-up vaccination strategy against Neisseria meningitidis C in Tuscany, Italy.
    Bechini A; Levi M; Boccalini S; Tiscione E; Balocchini E; Canessa C; Azzari C; Bonanni P
    Vaccine; 2012 Oct; 30(45):6396-401. PubMed ID: 22921931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Meningococcal disease due to serogroup Y in Scotland, 1992-1999.
    Clarke SC; Reid J; Thom L; Denham BC; Edwards GF
    Br J Biomed Sci; 2001; 58(1):17-9. PubMed ID: 11284218
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Annual report of the Australian Meningococcal Surveillance Programme, 2011.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2012 Sep; 36(3):E251-62. PubMed ID: 23186236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Outbreaks of group B meningococcal disease--Florida, 1995 and 1997.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1998 Oct; 47(39):833-7. PubMed ID: 9780239
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morbidity, mortality and spatial distribution of meningococcal disease, 1974-2007.
    Howitz M; Lambertsen L; Simonsen JB; Christensen JJ; Mølbak K
    Epidemiol Infect; 2009 Nov; 137(11):1631-40. PubMed ID: 19327198
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Meningococcal disease--New England, 1993-1998.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1999 Jul; 48(29):629-33. PubMed ID: 10458536
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serogroup B meningococcal disease--Oregon, 1994.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Feb; 44(7):121-4. PubMed ID: 7845348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization of Neisseria meningitidis B:NT:P1.14/162 clonal complex responsible of invasive meningococcal disease in the north of Italy.
    Neri A; Fazio C; Carannante A; Mastrantonio P; Stefanelli P
    Diagn Microbiol Infect Dis; 2012 Apr; 72(4):370-2. PubMed ID: 22313628
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Annual report of the Australian Meningococcal Surveillance Programme, 2007.
    Tapsall J;
    Commun Dis Intell Q Rep; 2008 Sep; 32(3):299-307. PubMed ID: 19062765
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Study of hypervirulent complexes of Neisseria meningitidis by methods of molecular biology and possibility of their prevention in the Czech Republic by vaccination].
    Krizová P; Kalmusová J; Musílek M
    Epidemiol Mikrobiol Imunol; 2009 Nov; 58(4):188-96. PubMed ID: 21114007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.